Navigation Links
A breakthrough in understanding the biology and treatment of ovarian cancer
Date:2/21/2012

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the presence and integrity of the opioid growth factor receptor (OGFr), which mediates the inhibitory action of opioid growth factor (OGF) on cell proliferation, is a key to understanding the progression and treatment of human ovarian cancer. Transplantation of human ovarian cancer cells that were molecularly engineered to have a reduced expression of OGFr, into immunocompromised mice resulted in ovarian tumors that grew rapidly. This discovery, reported in the February 2012 issue of Experimental Biology and Medicine, provides fresh new insights into the pathogenesis and therapy of a lethal cancer that is the fifth leading cause of cancer-related mortality among women in the USA, and has a death rate that is unchanged for over 75 years.

The OGF (also-termed [Met5]-enkephalin)-OGFr axis plays a fundamental role in cancer, development, and cellular renewal by regulating cell proliferation. An important question addressed in this study relates to the requirement of this peptide-receptor system for the progression of carcinogenesis. Human ovarian cancer cell lines that were genetically modified to underexpress OGFr grew far more rapidly in tissue culture than control (empty vector/wildtype) cell lines. Moreover, the addition of OGF to cultures of these genetically modified cells did not respond to the inhibitory peptide and change cell number, indicating that the loss of OGFr interfered with the function of the OGF-OGFr axis with respect to regulating cell proliferation. Immunocompromised mice injected with ovarian cancer cells that had a reduction in OGFr displayed tumors much earlier than controls, and these tumors grew faster than controls. Putting this information together with knowledge that the pathway for OGF-OGFr regulation of cell proliferation in ovarian cancer is by way of increasing the cyclin-dependent inhibitory kinas
'/>"/>

Contact: Dr. Ian Zagon
isz1@psu.edu
Society for Experimental Biology and Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Breakthrough optical technology to assess colon cancer risk, accuracy
2. Sandia, SES win Popular Mechanics Breakthrough Innovator Award
3. NC State finds new nanomaterial could be breakthrough for implantable medical devices
4. Adult stem cell breakthrough
5. A scientific breakthrough on the control of the bad cholesterol
6. Fly guy makes memory breakthrough
7. Researchers make breakthrough in the production of double-walled carbon nanotubes
8. Key to future medical breakthroughs is systems biology, say leading European scientists
9. World breakthrough in treating premature babies
10. Mount Sinai Hospital researcher makes stem cell breakthrough
11. Stem cell breakthrough gives new hope to sufferers of muscle-wasting diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) ... Global Market Overview" report to their offering. , ... ensure that an individual is who she/he is claiming to ... of a person,s unique physical characteristics, such as fingerprint, hand ...
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... Showcase, Hall E -   EyeLock Inc. , a market ... showcase its EyeLock ID technology integrated in a 3D printed ... Oak Ridge National Laboratory (ORNL) at the 2015 ... technology is being used to validate the driver and authorize ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... EAST LANSING, Mich. Two lines of pest-resistant soybean ... healthier harvests for growers and a little green for ... Shield" is the new trade name for genetics developed ... soil science tested some 2,000 strains of soybeans against ...
... Prairie dogs, once abundant in the Rocky Mountains ... by plague a virulent bacterial disease spread by ... dog towns with thousands of inhabitants, killing virtually the ... and build a new colony, which eventually is wiped ...
... The American Chemical Society (ACS) will hold a special ... National Meeting & Exposition, featuring international authorities speaking on the ... Change Science and Consequences," it is scheduled for 5 p.m. ... and will include time for audience participation. The ...
Cached Biology News:Pest-resistant soybeans grow out of MSU research lab 2Carnivorous mice spread deadly plague in prairie dog towns, Stanford study finds 2Carnivorous mice spread deadly plague in prairie dog towns, Stanford study finds 3Carnivorous mice spread deadly plague in prairie dog towns, Stanford study finds 4American Chemical Society to hold forum on climate change on Aug. 23 2
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Mature Biotech Outlook 2015: New Therapy Ventures ... offering. All biotech companies - Gilead ... in past year, have given a positive return and ... have been able to select therapy/niche indication where the ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 The next ... have received the CE mark (European) approval. The CE ... Free Trade Association (EFTA) and the European Union. Following ... now been granted to implants supplied by the Turkey-based ... conditions. , Osimplant's Cervical Expandable Bladed HA PEEK ...
(Date:3/4/2015)... -- In an article published and posted online today, ... review the clinical aspects of diseases caused by 5 ... article, "Clinical Management of Potential Bioterrorism-Related Conditions," was published ... New England Journal of Medicine . ... Tom Inglesby—review the clinical management of conditions resulting from ...
(Date:3/4/2015)... March 04, 2015 USDM Life ... the life sciences industry, hired David Blewitt ... Cloud Compliance Services and Solutions at USDM Life ... based applications while maintaining compliance with government regulations worldwide. ... been an accomplished life sciences regulatory and IS compliance ...
Breaking Biology Technology:Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3Latest Clinical Information On Bioterrorism Threats 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3
... BERLIN and BURLINGTON, Mass., May 9, 2011 ... offering the proprietary Capture Compound Mass Spectrometry (CCMS) platform ... interactions, today announced a second closing of EUR 1 ... total equity for the round to EUR 5 million ...
... Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a ... for the quarter ended March 31, 2011. For the first ... compared to net revenues of $45.5 million in the first ... of 2011 was $(11.8) million, or $(0.25) per share, compared ...
... LONDON, May 8, 2011 Trimega Laboratories is ... European Business Awards, sponsored by HSBC, to represent the United ... stiff competition to be selected as one of 25 Country ... for The UKTI Award for Innovation, in recognition of Trimega,s ...
Cached Biology Technology:caprotec bioanalytics Increases Series B Financing in Second Closing to EUR 5 Million 2Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 2Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 3Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 4Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 5Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 6Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 7Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 8Trimega Laboratories Honoured to Represent UK at the European Business Awards 2Trimega Laboratories Honoured to Represent UK at the European Business Awards 3
...
... PCR specificity *High PCR specificity ... with unique QIAGEN PCR Buffer ... by the stringent built-in hot start ... Mix and simple reaction setup at ...
... Nuclear matrix proteins (NMPs) make up the internal ... with such functions as DNA replication, RNA synthesis, ... has been shown to be highly insoluble ... cell death releases soluble nuclear matrix proteins that ...
Request Info...
Biology Products: